Swiss drugs regulator looking into BUBBLES in covid booster vials

Swiss drugs regulator Swissmedic said on Wednesday it is examining potential risks in connection with bubbles that appeared in vials of COVID-19 vaccine boosters retooled to target the Omicron variant of the coronavirus

https://www.blick.ch/schweiz/risiko-abklaerungen-im-gang-swissmedic-informiert-ueber-blasenbildung-in-pfizer-impfstoff-id18016412.html

Reports of formation of bubbles in a batch of the COVID-19 vaccine Comirnaty Bivalent Original/Omicron BA.1
risks currently being investigated

Swissmedic has been informed of the appearance of bubbles during preparation of the vaccine Comirnaty Bivalent Original/Omicron BA.1. Swissmedic is examining the potential risks in connection with the changes observed. As a precautionary measure, Swissmedic has informed the cantons and vaccination centres.

Source: https://www.swissmedic.ch/swissmedic/en/home/news/coronavirus-covid-19/comirnaty-bivalent-risikoabklaerung.html

Translate »